BCGU 2026 AGENDA
| 6:00 – 9:30 PM | Registration test | |
| 7:30 PM | Welcome Address | Dr. Christian Kollmannsberger, GUTG Chair |
| 7:15 – 9:30 PM | Welcome Dinner Reception | English Bay Room |
Saturday, April 18th, 2026
All Sessions Include 25% of Time for Question Periods and Audience Participation
| 7:00 – 8:00 AM | Breakfast | English Bay Room |
| 8:00 – 8:05 AM | Welcoming Remarks for Day 1 | Dr. Krista Noonan, GUTG Systemic Chair Grand Ballroom |
Prostate Session
Chairs: Drs. Jaco Fourie, Eric Sonke
| 8:00 – 8:20 AM | Salvage Therapy for Prostate Cancer Post-RT: Prostatectomy, HIFU, Cryoablation, Brachytherapy or SBRT? | Drs. Juanita Crook & Abraham Alexander |
| 8:20 – 8:25 AM | Questions & Answers with the Audience | |
| 8:25 – 8:45 AM | ADT-ARPI for High-Risk Localised Prostate Cancer: Who, What, How Long? | |
| 8:45 – 8:50 AM | Questions & Answers with the Audience | |
| 8:50 – 9:10 AM | Panel: PSMA-PET Oligometastatic Prostate Cancer: Minimalist Approach or Maximum Therapy | Drs. Srini Raman, Joana Vergidis, Justin Lee & Stacy Miller |
| 9:10 – 9:15 AM | Questions & Answers with the Audience | |
| 9:15 – 9:35 AM | Treatment intensification in mCSPC Beyond ARPI and Docetaxel: Benefit or Added Toxicity ? | Dr. Sunil Parimi |
| 9:35 – 9:40 AM | Questions & Answers with the Audience |
Special Session: Radioligand Therapy in BC
Chairs: Drs. Don Wilson, Kian Khodadad & Omar Nazif
| 9:40 – 10:00 AM | SPECT-CT 101 for Clinicians | Dr. James Curtis |
| 10:00 – 10:05 AM | Questions & Answers with the Audience | |
| 10:10 – 10:15 AM | Optimising Patient Selection for Radioligand Therapy | Dr. Kim Chi |
| 10:15 – 10:20 AM | Questions & Answers with the Audience | |
| 10:20 – 10:30 AM | Progress on Pluvicto – State of Abairs in BC | |
| 10:30 – 10:35 AM | Questions & Answers with the Audience | |
| 10:35 – 10:50 AM | Health Break & Networking | English Bay Room |
RCC Session
Chairs: Drs. Susan Ellard, Meredith Hunter & Matthew Ho
| 10:50 – 11:10 AM | Adjuvant Therapy: Has the Recommendation Changed? | Dr. Roxana Astani |
| 11:10 – 11:15 AM | Questions & Answers with the Audience | |
| 11:15 – 11:35 AM | Second line and Beyond in Metastatic RCC: Are there New Standards? | |
| 11:35 – 11:40 AM | Questions & Answers with the Audience | |
| 11:40 – 12:00 PM | Chronoimmunotherapy – Does Timing of ICI Administration Really Matter | Dr. Guliz Ozgun |
| 12:00 – 12:05 PM | Questions & Answers with the Audience | |
| 12:05 – 12:25 PM | Functional Imaging in RCC: Useful? If Yes, What Tracer / Method | Dr. Patrick Martineu |
| 12:25 – 12:30 PM | Questions & Answers with the Audience | |
| 12:30 – 1:15 PM | Lunch / Networking / Exhibition | English Bay Room |
Special Session: Oncology Research in BC
Chairs: Drs. Gang Wang, Andrew Attwell & Jim Rose
| 1:15 – 1:30 PM | miRNA 371 for Testis Cancer | Dr. Lucia Nappi |
| 1:30 – 1:45 PM | Drug development in GU Cancers | Dr. Mads Daugaard |
| 1:45 – 2:00 PM | Urine tumor DNA in GU Cancers | Dr. Gillian Vandekerkhove |
| 2:00 – 2:15 PM | Transcriptomic Classifiers in Bladder Cancer | Dr. Ewan Gibb |
Testis Cancer Session
Chairs: Drs. Mike Metcalfe, Alice Newman, Shannon King & Winkle Kwan
| 2:15 – 2:35 PM | Robotic RPLND in testis cancer | Dr. Mark Dawidek |
| 2:35 – 2:40 PM | Questions & Answers with the Audience | |
| 2:40 – 3:00 PM | Hypogonadism in Testicular cancer: How to Monitor, Test and When to Replace | Dr. Ryan Flannigan |
| 3:00 – 3:05 PM | Questions & Answers with the Audience |
Special Session: Opportunistic Salpingectomy
Chairs: Drs. Alym Abdulla, John Kinahan & Samrad Ghavimi
| 3:05 – 3:25 PM | Opportunistic salpingectomy | Dr. Heather Stuart |
| 3:25 – 3:30 PM | Questions & Answers with the Audience | |
| 3:30 – 3:35 PM | Closing Remarks for Day 1 | Dr. Nathan Hoag, BCUS Chair |
| 7:00 – 9:30 PM | BCGU Dinner | Grand Ballroom |
Sunday, April 19th, 2026
All Sessions Include 25% of Time for Question Periods and Audience Participation
| 7:00 – 8:00 AM | Breakfast | English Bay Room |
| 8:00 – 8:05 AM | Welcoming Remarks for Day 2 – Dr. Jack Zheng, GUTG RT Chair | Grand Ballroom |
Bladder Cancer Session
Chairs: Drs. Dallas Desrosiers, Brian Yang, Param Bains
| 8:05 – 8:25 AM | Debate: Non-muscle Invasive Bladder Cancer: Is Systemic Immunotherapy Standard of Care? | Yes: Dr. Peter Black No: |
| 8:25 – 8:30 AM | Questions & Answers with the Audience | |
| 8:30 – 8:50 AM | Perioperative Therapy in Muscle- Invasive Bladder Cancer: A Changing Paradigm | |
| 8:50 – 8:55 AM | Questions & Answers with the Audience | |
| 8:55 – 9:15 AM | Debate: Is ctDNA Ready for Prime Time? | Yes: Dr. Richard Gagnon No: Dr. Simon Yu |
| 9:15 – 9:20 AM | Questions & Answers with the Audience | |
| 9:20 – 9:40 AM | Panel: Bladder Sparing in MIBC: Illusion or Upcoming Reality? Chair: Marie-Pier St-Laurent |
Panel: Drs. Ren Yuan, Hamid Raziee & Ed Hardy |
| 9:40 – 9:45 AM | Questions & Answers with the Audience | |
| 9:45 -10:05 AM | What to Do after EVP? | Dr. Adam Fundytus |
| 10:05 – 10:10 AM | Questions & Answers with the Audience | |
| 10:10 – 10:30 AM | Novel Therapies on the Horizon | Dr. Archie Angeles |
| 10:30 – 10:35 AM | Questions & Answers with the Audience | |
| 10:35 – 10:55 AM | Health Break / Networking / Exhibition / Check-out | English Bay Room |
Prostate Cancer Session 2: mCRPC
Chairs: Drs. Lyly Le, Arthur Cheung, & Chris Hoag
| 10:55 – 11:15 AM | Diagnosis and Treatment of Neuroendocrine Prostate Cancer | Dr. Corinne Maurice-Dror |
| 11:15 – 11:20 AM | Questions & Answers with the Audience | |
| 11:20 – 11:40 AM | Beyond DDR: How Can Genomics/Transcriptomics Inform Our Practice? | Dr. Alex Wyatt |
| 11:40 – 11:45 AM | Questions & Answers with the Audience | |
| 11:45 – 12:05 PM | Docetaxel Chemotherapy for Prostate Cancer in BC: Proven Benefit but Not Utilized | Dr. Jenny Ko |
| 12:05 – 12:10 PM | Questions & Answers with the Audience | |
| 12:10 – 12:30 PM | Novel Treatment Options: T-Cell Engagers | Dr. Lucia Nappi |
| 12:30 – 12:35 PM | Questions & Answers with the Audience | |
| 12:35 PM | BCGU Conference Closing Remarks | Dr. Christian Kollmannsberger, GUTG Chair |